SCHEMBL4711537

SCHEMBL4711537

CCOC(=O)c1oc2nc(OC)c3c(c2c1N)CC(C)(C)CC3

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 15/20 0.59
KDM4E B2RXH2 14/20 0.59
HPGD P15428 10/20 0.59
HSD17B10 Q99714 5/20 0.59
TSHR P16473 2/20 0.56
RECQL P46063 1/20 0.56
GAA P10253 3/20 0.53
MAPT P10636 3/20 0.52
MAPK1 P28482 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C19 P33261 1/20 0.52
HTT P42858 1/20 0.52
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
NPSR1 Q6W5P4 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4708645 0.81 KDM4E (0.54) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL4707161 0.72 ALDH1A1 (0.79) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL24256901 0.70 KDM4E (0.77) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL4706598 0.68 KDM4E (0.71) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL4922607 0.68 ALDH1A1 (0.49) ALDH1A1TSHRKMT2A
SCHEMBL4925674 0.67 ALDH1A1 (0.50) ALDH1A1TSHRNPSR1POLBKMT2A
SCHEMBL19740957 0.66 KDM4E (0.76) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL30916867 0.66 KDM4E (0.76) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL4708892 0.66 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL19741371 0.66 KDM4E (0.56) ALDH1A1KDM4EHPGDHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221096-A1 Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives LABORATORIOS ALMIRALL, S.A. (ES) 2008-09-11 US disclosed
EP-1913003-A1 NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES Laboratorios Almirall, S.A. (ES) 2008-04-23 EP disclosed
WO-2007017078-A1 NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES LABORATORIOS ALMIRALL, S.A. (ES) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221096-A1 Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives NR1H2, CBR3, NR4A1 ALDH1A1 2625/4885KDM4E 3618/4885HPGD 1978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.